Coldstream Capital Management Inc Uro Gen Pharma Ltd. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 29 shares of URGN stock, worth $313. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29Holding current value
$313% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
142Shares Held
37.5MCall Options Held
77.9KPut Options Held
42.6K-
Rtw Investments, LP New York, NY3.83MShares$41.5 Million0.69% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$24.9 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$23.7 Million0.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$18.9 Million0.03% of portfolio
-
Vestal Point Capital, LP New York, NY1.63MShares$17.6 Million1.03% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $246M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...